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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA), one of the major pathogens in humans, is a cause of infection and colonization among
animals. The increasing number of companion animals and antibiotic use have made this population a reservoir of MRSA. In parallel, the
evolution of new MRSA clones and mec homologues among animals of the food chain has emphasized the need for infection control
practices in animals and humans in close contact. On the basis of a review of the literature, epidemiological and evolutionary data for
MRSA infections and carriage, risk factors and control strategies are presented.
Keywords: Companion animals, humans, infections, livestock, methicillin-resistant S. aureus
Article published online: 30 March 2012
Clin Microbiol Infect 2012; 18: 626–634
Corresponding author: I. Spiliopoulou, Department of Microbiol-
ogy, School of Medicine, University of Patras, Rion, 26504 Patras,
Greece
E-mail: spiliopl@upatras.gr
Introduction
Staphylococcus aureus is one of the most virulent and thus
dangerous pathogens for humans [1]. It is the causative agent
of a variety of deep-seated invasive and toxin-mediated dis-
eases, as well as superficial infections [1]. This broad range
of clinical syndromes results from a variety of extracellular
components, including surface proteins, capsule, biofilm for-
mation, enzymes, and toxins [1,2]. Additionally, MRSA has
the capacity to acquire antibiotic resistance determinants,
with the main step being the development of resistance to
b-lactams, first by b-lactamase production and then by the
acquisition of mec determinants [1]. Methicillin-resistant
S. aureus (MRSA) was first identified in the UK, and was then
recognized as a hospital-associated pathogen worldwide
(hospital-associated MRSA (HA-MRSA)) [3–5]. Molecular
analysis has so far revealed 11 staphylococcal chromosomal
cassettes (SCCs) (SCCmec types I–XI) carrying mecA or
mecA homologues that encode the modified penicillin-binding
protein, PBP2a, associated with clones of human or animal
origin [5–8]. Different SCCs have incorporated several addi-
tional antibiotic resistance genes, but the smallest ones (type-
s IV and V) include only mecA [6–9]. MRSA express
resistance to multiple antibiotics, such as tetracyclines, fusidic
acid, fluoroquinolones, macrolides, lincosamides, aminoglyco-
sides, and glycopeptides [10,11]. Resistance development has
been shown to be associated with antibiotic use in humans
and animals [9,11].
During 1997, the first reports of MRSA infections among
individuals without previous predisposing risk factors were
published, and since then community-associated MRSA (CA-
MRSA) infections and outbreaks have been reported
throughout the world [11]. Molecular epidemiology has
revealed differences between HA-MRSA and CA-MRSA, such
as resistance determinants, SCCmec types and clonal
complexes (CCs) identified by multilocus sequence typing
(MLST) or spa typing [11,12]. The spread of specific clones
in different countries shows a geographical area-dependent
epidemiology, owing either to pre-existing methicillin-sensi-
tive S. aureus (MSSA) strains that have acquire the mec
determinants, or to the successful spread of MRSA clones.
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During the 1970s, the first reports of MRSA infections in
animals appeared, and, on the basis of their putative source,
these MRSA strains are referred to as livestock-associated
MRSA (LA-MRSA) [13]. For several years, it was supposed that
their evolution was a result of antibiotic use in animals, and
their impact on humans was not investigated. Today, increasing
numbers of reports are being published on outbreaks in com-
panion and livestock animals, as well as in humans who are in
close contact with these [14]. The question posed by Morgan,
‘zoonosis or humanosis’, reflects the complex epidemiology of
MRSA strains isolated from animals and their impact on
humans [15]. Questions still remain regarding whether animals
or humans represent the reservoirs of MRSA with the poten-
tial to cause outbreaks under certain conditions.
In the present article, we have reviewed the literature con-
cerning the epidemiology of MRSA in companion animals such
as cats, dogs, other pets, marine mammals, and horses, and in
livestock, including animals of the human food chain, such as
chickens, pigs, sheep, and cows. This epidemiology is corre-
lated with humans who are in close contact with the aforemen-
tioned animals, i.e. owners, farmers, and veterinary personnel.
MRSA Among Companion Animals
MRSA in pets
The first outbreak among humans that had its origin in pets
was described in 1988, caused by a cat in a geriatric ward,
where close contact of patients with the colonized pet led
to re-infections [16]. The first description of MRSA in a dog
was reported in 1994 [17]. Since then, several investigators
have reported MRSA spread among pets, household con-
tacts, and veterinary personnel [14,18,19]. In most cases, the
MRSA were of human origin, and this was proved by MLST
and SCCmec typing of strains isolated from healthy and
infected pets. In Australia, the MRSA belonged to the HA-
MRSA clone ST239-III, whereas the detection of SCCmec IV
in coagulase-negative staphylococci suggested continuous
evolution of staphylococcal clones in the animal setting [20].
Similar data were obtained in France, with the identification
of clones of human origin among pets; however, three of 23
animals carried LA-MRSA CC398 [21].
The carriage of toxin genes has differed among studies,
with MRSA carrying the Panton–Valentine leukocidin (PVL)
genes being recovered from pets and humans [15,22], and, in
Germany, MRSA from pets being PVL-negative and belonging
to the HA-MRSA clone ST22-IV [23].
In a review on antimicrobial use in dogs and cats, it was
reported that broad-spectrum agents and other pharmaceuti-
cal components accounted for 36.5% of animal health sales
in the EU during 2002, determining the rate of resistance
development and spread of pathogenic bacteria, including
MRSA [19]. The inappropriate use of antibiotics was attribut-
able to the fact that isolation, identification and susceptibility
tests were performed rarely in pets [19]. Multiresistant iso-
lates were identified in pets, suggesting the need for continu-
ous surveillance among animals [24–27].
All studies on MRSA colonization or infection among pets
have shown that both human-to-animal and animal-to-human
transmission occur, and that environmental sources in veteri-
nary clinics, veterinary staff and other hospitalized animals play
a crucial role [26,28–31]. Significant risk factors for MRSA
infection among companion animals are previous antibiotic
treatment, number of antimicrobial courses, number of hospi-
talization days, implant devices, surgical interventions and con-
tact with humans who have been previously hospitalized
[15,20,25,26]. These factors are similar to those defining
HA-MRSA infections in humans [4,5,9,10]. Search and destroy
strategies that lead to the prevention of MRSA transmission,
focusing on the eradication of carriage, can be applied [29].
The problem with most investigations was that pets tested
for the presence of MRSA were already infected and unsuc-
cessfully treated before samples were taken. Additionally, dif-
ferences in the protocols that were applied for MRSA
carriage (number of collected samples and enrichment proto-
cols) may be responsible for an underestimation of the true
percentage of MRSA-positive pets.
MRSA in horses
The first outbreak among horses was reported in a veteri-
nary hospital in Michigan [32]. To date, several investigators
have detected the presence of MRSA among horses in Eur-
ope, America, and Asia, with slight differences in prevalence
being found [14,15,33–37]. In most equine cases of MRSA
carriage or infection, the characterized clones were different
from those recovered from pets or humans, identifying
strains of CC8 where sequence types formerly associated
with human HA-MRSA infections are included [33,34,37,38].
In central Europe, besides CA-MRSA clones ST1 and ST254,
which belong to CC8, LA-MRSA clone ST398 was identified
in horses [39–41]. In a study conducted in the Greater Lon-
don area among companion animals, only three of 152
horses were MRSA-positive, and the strains belonged to
HA-MRSA clones CC22 and CC8/ST239 and LA-MRSA
clone ST398 [35]. In Germany, a switch from human-asso-
ciated S. aureus clones to pig farm-origin clone ST398 was
reported during 2006 [42]. This change in equine MRSA clo-
nal distribution was also observed in Switzerland in a study
including 70 S. aureus strains collected from 2005 to 2011,
where ST398 emerged during 2007 [43]. Risk factors for
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MRSA infections among horses were topical antimicrobial
therapy, systemic glucocorticoid use, and one visit by a vet-
erinary surgeon [35]. These results emphasize the fact that
the increase in equine MRSA infection or colonization is
associated with antibiotic treatment, immunosuppression,
and hospitalization.
MRSA in marine mammals
Few studies have investigated MRSA among marine mammals.
In the study of O’Mahony et al. [33], MRSA was isolated from
one seal post-mortem after treatment, and pulsed-field gel
electrophoresis (PFGE) showed 71% similarity with strains of
human origin. Faires et al. [44] have reported an infection con-
trol practice after the death of a dolphin from pneumonia
caused by MRSA belonging to the Canadian epidemic HA-
MRSA clone (USA100). All marine mammals and park person-
nel were tested for MRSA carriage, and three strains were
recovered from dolphins and a walrus, whereas the personnel
were negative [44]. This study showed the possibility of
waterborne transmission, transient colonization of the mam-
mals, and the need to apply infection control measures.
MRSA transmission from companion animals to humans
and vice versa
Pets are able to exchange resistant pathogens with humans, as
shown by epidemiological studies performed in different
countries. In the UK, where MRSA carriage was investigated
among pets, staff, and environmental surfaces, PFGE revealed
the spread of EMRSA-15, which is the HA-MRSA clone in the
UK [45]. The same HA-MRSA clone was identified in a study
conducted in Ireland in veterinary clinics throughout the
country, where MRSA was recovered from pets and staff
[33]. HA-MRSA clone ST5-II was identified in dogs and hospi-
talized humans in Korea, reinforcing the fact that human-to-
animal transmission and animal-to-human transmission occur
[46]. The same clone, related to USA100, which is of hospital
origin and causes community-associated infections in Canada,
was identified among dogs, cats, and humans [31].
Besides clonality, the exchange of toxinogenic strains is
important. This has been shown by the identification of en-
terotoxinogenic S. aureus isolates among pets and humans
[47,48], and this might also be correlated with the spread of
CCs with a certain toxinogenic profile [49]. In an ongoing
study in Greece, nine MRSA strains were identified from 29
pets and five owners; five of these strains were PVL-positive
and belonged to ST80, the CA-MRSA clone that has spread
in Greece (E. Drougka, A. Foka, R. Farmaki, C. Koutinas, E.
D. Anastassiou, I. Spiliopoulou, unpublished data).
Veterinary staff in equine hospitals are colonized or
infected by strains of animal origin that are not related to
the human lineages in the same regions [18,33]. Most
reports have shown that MRSA strains from horses and
humans in close contact differ from those spread in the
human population or pets. In Canada, a CA-MRSA clone has
been isolated from horses (ST8-IV), and has become well
adapted to the animal setting [50]. In central Europe, LA-
MRSA ST398 has emerged since 2006 in equines, and horse-
to-human transmission has also been reported in The Neth-
erlands [42,51].
Differences in the prevalence of MRSA colonization or infec-
tion among companion animals and humans may reflect differ-
ences in the duration of close contact, the humans’ MRSA
epidemiology, the timing of sample collection from animals
(previous antibiotic therapy), and the protocols applied to
search for carriage (sites tested and enrichment protocols).
The majority of studied MRSA isolates recovered from pets
belonged to clones causing human infections, and followed the
epidemiology of the particular geographical area. Veterinary
staff carried isolates related to the animal species attended by
them [34]. According to these epidemiological findings, and tak-
ing into account the use of antibiotics in veterinary medicine,
the application of preventive strategies is of great importance.
MRSA Among Food-chain Animals
LA-MRSA
The first report of MRSA in farm animals was published in
the early 1970s, when the bacteria were isolated from the
milk of dairy cows with mastitis in Belgium [52,53]. Recent
reports of MRSA in livestock, particularly pigs, and in individ-
uals with contact with livestock provided the first evidence
of the existence of an LA-MRSA reservoir throughout
Europe [54,55]. Since then, LA-MRSA has been identified in
Canada, the USA, China, Malaysia, and Korea [56–62].
LA-MRSA strains have important genotypic and phenotypic
characteristics (reviewed in [63]: (i) they are non-typeable by
PFGE using SmaI [64]; (ii) many of them belong to CC398 by
MLST; (iii) SCCmec elements are different from those car-
ried by other MRSA genotypes commonly found in the com-
munity and healthcare settings [7]; (iv) they often exhibit co-
resistance to many non-b-lactam antimicrobials (e.g. antibiot-
ics and metals), including those commonly used in animal
production [65]; and (v) the majority of isolates lack toxins
such as PVL and other enterotoxins [66]. MLST showed that
LA-MRSA strains from Europe and North America belong to
CC398, whereas the vast majority of LA-MRSA strains from
Asia belong to CC9 [54–62].
Potential risk factors for LA-MRSA prevalence are antibi-
otic treatment, the duration of the treatment, and farm
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hygiene [67]. Previously, Graveland et al. [68] showed that
farm animals carrying MRSA are more often treated with
antibiotics. This is the strongest evidence to date of a direct
relationship between antibiotic use in animals and the trans-
fer of antimicrobial-resistant organisms to humans. In the
same study, people in close contact with farm animals had a
highly elevated risk of MRSA carriage. Few studies have
investigated risk factors for the occurrence of LA-MRSA in
humans. A high level of animal-to-human transmission of LA-
MRSA has been reported in pig farming [69]. In these stud-
ies, a large difference in MRSA prevalence was observed
between the farmer and family members, which is indicative
of a comparable role for intensive animal contact as a risk
factor for LA-MRSA occurrence [70,71].
MRSA in pigs
The first cases of MRSA in pigs were reported from The
Netherlands in 2005 [55]. It appears that pigs normally dis-
play no symptoms of illness. Instead, with MRSA in their
noses, on their skin, and probably in their intestines, they
act as an army of carriers. Airborne MRSA colonization
occurred at slaughter and inside pig sheds [72]. Soon after
the isolation of MRSA in Dutch pigs, rapid dissemination
occurred among pigs in countries other than The Nether-
lands [73,74]. One explanation for this spread is that, in
addition to producing large quantities of pork and bacon for
export, The Netherlands is also Europe’s largest exporter of
live pigs. Young Dutch pigs are exported to Italy, Spain,
Belgium, Hungary, Croatia, Romania, and Poland, but not to
the UK. About 3 000 000 Dutch pigs are exported to
Germany each year, but most of these go directly to be
slaughtered.
Various studies have revealed the presence of LA-MRSA
in pigs in Germany, France, and Belgium [75,76]. There is
also a significant MRSA problem with pigs in Canada and the
USA [56,77]. In Europe and North America, LA-MRSA
belongs predominantly to CC398, whereas in Asia a novel
LA-MRSA clone, ST9, seems to be dominant in pigs [58].
Recently, in a study conducted in Peru, 13% of pigs had
MRSA; 93% of these isolates corresponded to LA-MRSA
CC398, 4% to CA-MRSA CC30-V, and one to CC1 [78]. In
2009, a new LA-MRSA type, ST49, was detected in slaughter
pigs in Switzerland [79]. In addition, in a study from northern
Spain, Go´mez-Sanz et al. [80] showed that slaughter pigs
were frequently colonized by LA-MRSA CC398; moreover,
strains belonging to CA-MRSA CC97 were detected. The
identification of new clones underlines the fact that other
new lineages are also able to spread in livestock, and empha-
sizes the need to establish effective hygiene measures to sup-
press the spread of these pathogens into the community.
MRSA in cattle
The first report of MRSA in farm animals was published in
the early 1970s, when the bacteria were isolated from the
milk of dairy cows with mastitis in Belgium [52,53]. In the
past few years, MRSA has been isolated from cows (or their
milk) in Korea, Hungary, Mexico, and The Netherlands [81–
84]. There have also been numerous reports of MRSA from
cows or their milk in Brazil, Italy, Pakistan, Nigeria, Turkey,
and the USA [85–89].
Subsequently, several reports have described bovine udder
infections caused by LA-MRSA ST398 [90]. Recently, another
group of LA-MRSA strains was discovered in humans and
dairy cattle in Europe. This group includes a number of
S. aureus lineages (CC130, ST425, and CC1943) that were
hitherto thought to be bovine-specific, but are now also
found as carriage or clinical isolates in humans [91]. The
emergence of MRSA in dairy cattle may be associated with
contact with other host species, as in the case of LA-MRSA
ST398, or with the exchange of genetic material between
S. aureus and coagulase-negative staphylococci, which are the
most common species associated with bovine intramammary
infections and commonly carry antimicrobial resistance
determinants. A new mec determinant, mecALGA251, sharing
70% homology with mecA, was recently identified among
MRSA strains recovered from cattle and humans [92]. This
finding confirms the continuous evolution of S. aureus strains
in the animal and human settings.
MRSA in sheep
Very few studies have reported the prevalence of MRSA in
sheep. Overall antibiotic use tends to be much lower in
sheep than in pigs, poultry, or dairy cows, which may result
in a low prevalence of MRSA [93]. However, antibiotics are
likely to be used in greater quantities in herds of dairy sheep,
particularly for the treatment or prevention of mastitis, and
in some flocks lambed indoors, where they are used rou-
tinely in young lambs to prevent both Escherichia coli infec-
tions and navel ill. A Spanish study examined 38 S. aureus
isolates taken from dairy sheep flocks, and found that one
isolate showed methicillin resistance. However, the bacteria
were not tested for the presence of mecA [94]. Meat sam-
ples from sheep were also tested in the Jordanian study. Of
717 samples collected in the Amman area, six (0.8%) were
positive for MRSA [95].
MRSA in chicken meat
The finding in a chicken farm of an MRSA isolate that was
apparently the same as the MRSA isolate previously found in
pig farms in The Netherlands gave a new perspective on a
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report, published in November 2006, of a serious LA-MRSA
ST398 infection in a Dutch woman [96]. This case concerned
a 63-year-old woman who developed a life-threatening heart
infection, endocarditis. Although the Dutch authorities have
recognized that pig farmers, abattoir workers and veterinari-
ans are at high risk of acquiring ST398, she was not in any of
these risk groups. However, she and her husband did have a
chicken farm and lived close to a pig farm [96].
Several studies have found MRSA in retail chicken meat. In
a study conducted in Korea, 930 foodstuff samples were col-
lected, and four strains of the CA-MRSA ST5 human clone
were identified [46]. Host adaptation of ST5 from humans to
chickens was associated with a loss of genes contributing to
human pathogenesis, and this was followed by the acquisition
of avian-specific virulence determinants [97,98]. Although the
route of MRSA transmission from humans to foodstuffs is
not clear, there is always the possibility of the emergence of
toxinogenic and multiresistant strains. Whether this poses a
health problem needs further investigation.
MRSA transmission from farm animals to humans
The ways by which animal MRSA can be transmitted to
humans are direct contact with the animals, environmental
contamination, and eating or handling contaminated meat. As
when MRSA spreads between humans, direct contact is an
important way by which animal MRSA can be transmitted. As
a result, those who have direct contact with farm animals car-
rying LA-MRSA have the highest risk of acquiring farm animal
MRSA. A previous study showed that c. 50% of humans living
on Dutch pig farms were carriers, and some developed seri-
ous infections [99]. MRSA can also be transmitted between
cattle and farmers, and between chickens and farmers. Veteri-
narians are also at risk if the animals that they are handling are
infected with MRSA [100]. With regard to humans in contact
with farm animals, Voss et al. [55] reported in 2005 that
Dutch pig farmers were at a 760-fold risk of being colonized
with LA-MRSA as compared with the general Dutch popula-
tion. In an international study, Wulf et al. [101] found MRSA
in 12.5% of veterinarians originating from all over the world.
In Switzerland, the MRSA prevalence in veterinarians was 3%
in 2009 [102]. These studies strongly suggest that people
working with livestock are at potential risk of becoming MRSA
carriers, and hence have an increased risk of suffering infec-
tions caused by MRSA. Recently, the results of Price et al.
[103] strongly suggested that LA-MRSA CC398 originated in
humans as MSSA. The lineage appears to have undergone
rapid radiation in conjunction with the jump from humans to
livestock, where it subsequently acquired tetracycline and
methicillin resistance. The first outbreak of LA-MRSA ST398
was reported in a Dutch hospital; none of the patients had
had contact with pigs or veal calves [104]. This finding indi-
cates possible transmission from humans to humans. van Cleef
et al. [105] reported a low proportion of ST398 among MRSA
isolates from humans (1.17%) in eight of 15 European coun-
tries, and this was correlated with pig density. In Germany, in
regions with a high density of pig farming, where 25% of
patients admitted to a hospital were colonized with LA-MRSA,
only 7% had infection with the same clonal type, and it was
also shown that the CC398 lineage lacks virulence factors
[106]. Furthermore, the demographic data differed between
patients with HA-MRSA and LA-MRSA, influencing the risk of
infection [106]. In a survey of invasive S. aureus infections con-
ducted among 26 European countries, during a 6-month per-
iod, a total of 2890 isolates were studied [107]. LA-MRSA
ST398 constituted only 0.4% of the sample, and all were
MSSA, reinforcing the idea that strains of this lineage are not
frequent causes of systematic infections [107].
MRSA in meat
MRSA has been found in meat from pigs, cattle, chickens, and
sheep [81,95]. However, the percentage of MRSA in meat var-
ies from study to study [108–110]. The majority of these
MRSA isolates belong to LA-MRSA CC398, and a few belong
to CA-MRSA CC30 and LA-MRSA ST692 [78,111,112].
Recently, Ogata et al. [113] showed that commercially distrib-
uted meat could play a role in the prevalence of CA-MRSA in
the community. The European Food Safety Authority has pub-
lished an opinion on the public health significance of MRSA in
animals and foods. The European Food Safety Authority’s
Panel on Biological Hazards (BIOHAZ) found that, although
food may be contaminated by MRSA, there is currently no evi-
dence that eating or handling contaminated food leads to an
increased risk of humans becoming healthy carriers or
infected with this bacterium. The Panel also concluded that
where MRSA prevalence in food-producing animals is high,
people in contact with live animals, especially farmers, veteri-
narians, and their families, are at greater risk than the general
population. In addition, according to the BIOHAZ data, there
is no evidence to date that humans can become infected with
LA-MRSA CC398 from eating contaminated food, and neither
is there evidence that this strain has caused food poisoning.
Conclusions
MRSA remains a significant public health problem, even
though, in several countries, with the paradigm of the Scandi-
navian and The Netherlands, successful infection control mea-
sures have been applied. The spread of MRSA among
companion and food-chain animals has not been completely
630 Clinical Microbiology and Infection, Volume 18 Number 7, July 2012 CMI
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 626–634
investigated, for several reasons: the details of animal MRSA
carriage are not completely known, and different rates have
been published, reflecting transient carriage, a diversity of
applied protocols, and the variation in MRSA epidemiology
between countries. It is of great importance that multiresis-
tant isolates have been identified in animals, where, several
times, antibiotics have been supplied as growth factors and for
treatment of infections without prior culture and antibiotic
susceptibility testing. This makes the animals an ideal reservoir
of multiresistant strains. In parallel, the close contact of com-
panion and food animals with humans has made epidemiologi-
cal studies challenging with regard to interpretation of the
obtained results: among companion animals, it seems that
mainly human HA-MRSA and CA-MRSA clones are spread,
including from veterinary staff. The identified clones depend
on the epidemiology of the specific geographical region. From
livestock animals, new clones and new mec variants have
emerged that have colonized or infected humans in close con-
tact, farmers, and veterinarians. So far, LA-MRSA ST398 has
constituted a low proportion of MRSA infections in humans,
suggesting that it is a cause of less severe disease. Even though
LA-MRSA seems to be less virulent, an additional threat is the
capacity of S. aureus for toxin carriage and acquisition of new
genes after adaptation to the environment and host.
With these new data, efforts should be made to charac-
terize animal MRSA hosts and possible reservoirs, as well as
humans at risk. The implementation of infection control mea-
sures in veterinary hospitals and clinics, as well as in farms
and parks, is necessary in order to reduce the spread of
MRSA, a well-established bacterium.
Acknowledgements
No commercial relationship or potential conflict of interest
exists. The authors are responsible for the contents of this
publication. We thank E. Drougka for her contribution to
writing the manuscript.
Transparency Declaration
The authors declare that they have no conflicting interests in
relation to this work.
References
1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:
520–532.
2. Tristan A, Ferry T, Durand G et al. Virulence determinants in com-
munity and hospital methicillin-resistant Staphylococcus aureus. J Hosp
Infect 2007; 65: 105–109.
3. Jevon MP. Celbenin-resistant staphylococci. Br Med J 1961; 1: 124–
125.
4. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA,
Stobberingh EE. The molecular evolution of methicillin-resistant
Staphylococcus aureus. Clin Microbiol Infect 2007; 13: 222–235.
5. Deurenberg RH, Stobberingh EE. The molecular evolution of hospi-
tal- and community-associated methicillin-resistant Staphylococcus aur-
eus. Curr Mol Med 2009; 9: 100–115.
6. Ghaznavi-Rad E, Nor Shamsudin M, Sekawi Z, van Belkum A, Neela
V. A simplified multiplex PCR assay for fast and easy discrimination
of globally distributed staphylococcal cassette chromosome mec types
in methicillin-resistant Staphylococcus aureus. J Med Microbiol 2010; 59:
1135–1139.
7. Li S, Skov RL, Han X et al. Novel types of staphylococcal cassette
chromosome mec elements identified in clonal complex 398 methicil-
lin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother
2011; 55: 3046–3050.
8. Shore AC, Deasy EC, Slickers P et al. Detection of staphylococcal
cassette chromosome mec type XI carrying highly divergent mecA,
mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal
complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob
Agents Chemother 2011; 55: 3765–3773.
9. Moreillon P. New and emerging treatment of Staphylococcus aureus
infections in the hospital setting. Clin Microbiol Infect 2008; 14: 32–41.
10. Rybak MJ, Akins RL. Emergence of methicillin-resistant Staphylococcus
aureus with intermediate glycopeptide resistance: clinical significance
and treatment options. Drugs 2001; 6: 1–7.
11. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant
Staphylococcus aureus: a review. Pharmacotherapy 2005; 25: 74–85.
12. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt
BG. The evolutionary history of methicillin-resistant Staphylococcus
aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 7687–7692.
13. Leonard FC, Markey BK. Methicillin-resistant Staphylococcus aureus in
animals: a review. Vet J 2008; 175: 27–36.
14. Catry B, Van Duijkeren E, Pomba MC et al. Reflection paper on
MRSA in food-producing and companion animals: epidemiology and
control options for human and animal health. Epidemiol Infect 2010;
138: 626–644.
15. Morgan M. Methicillin-resistant Staphylococcus aureus and animals:
zoonosis or humanosis? J Antimicrob Chemother 2008; 62: 1181–1187.
16. Scott GM, Thomson R, Malone-Lee J, Ridgway GL. Cross-infection
between animals and man: possible feline transmission of Staphylococ-
cus aureus infection in humans? J Hosp Infect 1988; 12: 29–34.
17. Petersen AD, Walker RD, Bowman MM, Schott HC 2nd, Rosser EJ
Jr. Frequency of isolation and antimicrobial susceptibility patterns of
Staphylococcus intermedius and Pseudomonas aeruginosa isolates from
canine skin and ear samples over a 6-year period (1992–1997). J Am
Anim Hosp Assoc 2002; 38: 407–413.
18. Loeffler A, Lloyd DH. Companion animals: a reservoir for methicillin-
resistant Staphylococcus aureus in the community? Epidemiol Infect
2010; 138: 595–605.
19. Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of
antimicrobial-resistant bacteria. J Antimicrob Chemother 2004; 54: 321–
332.
20. Malik S, Coombs GW, O’Brien FG, Peng H, Barton MD. Molecular
typing of methicillin-resistant staphylococci isolated from cats and
dogs. J Antimicrob Chemother 2006; 58: 428–431.
21. Haenni M, Saras E, Chaˆtre P et al. A USA300 variant and other
human-related methicillin-resistant Staphylococcus aureus strains infect-
ing cats and dogs in France. J Antimicrob Chemother 2012; 67: 326–
329.
CMI Petinaki and Spiliopoulou MRSA among animals and humans 631
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 626–634
22. Rankin S, Roberts S, O’Shea K, Maloney D, Lorenzo M, Benson CE.
Panton Valentine leukocidin (PVL) toxin positive MRSA strains iso-
lated from companion animals. Vet Microbiol 2005; 108: 145–148.
23. Strommenger B, Kehrenberg C, Kettlitz C et al. Molecular character-
ization of methicillin-resistant Staphylococcus aureus strains from pet
animals and their relationship to human isolates. J Antimicrob Chemo-
ther 2006; 57: 461–465.
24. Loeffler A, Baines SJ, Toleman MS et al. In vitro activity of fusidic acid
and mupirocin against coagulase-positive staphylococci from pets. J An-
timicrob Chemother 2008; 62: 1301–1304.
25. Soares Magalha˜es RJ, Loeffler A, Lindsay J et al. Risk factors for meth-
icillin-resistant Staphylococcus aureus (MRSA) infection in dogs and
cats: a case–control study. Vet Res 2010; 41: 55; doi:10.1051/vetres/
2010028.
26. Faires MC, Traverse M, Tater KC, Pearl DL, Weese JS. Methicillin-
resistant and -susceptible Staphylococcus aureus infections in dogs.
Emerg Infect Dis 2010; 16: 69–75.
27. Lloyd DH. Reservoirs of antimicrobial resistance in pet animals. Clin
Infect Dis 2007; 45: 148–152.
28. Hanselman BA, Kruth SA, Rousseau J, Weese JS. Coagulase positive
staphylococcal colonization of humans and their household pets. Can
Vet J 2009; 50: 954–958.
29. Bo¨cher S, Skov RL, Knudsen MA et al. The search and destroy strat-
egy prevents spread and long-term carriage of methicillin-resistant
Staphylococcus aureus: results from the follow-up screening of a large
ST22 (E-MRSA 15) outbreak in Denmark. Clin Microbiol Infect 2010;
16: 1427–1434.
30. Morris DO, Lautenbach E, Zaoutis T, Leckerman K, Edelstein PH,
Rankin SC. Potential for pet animals to harbor methicillin-resistant
Staphylococcus aureus when residing with human MRSA patients. Zoo-
noses Public Health 2012; doi: 10.1111/j.1863-2378.2011.01448.x. Jan
10 [Epub ahead of print].
31. Weese JS, Dick H, Willey BM et al. Suspected transmission of methi-
cillin-resistant Staphylococcus aureus between domestic pets and
humans in veterinary clinics and in the household. Vet Microbiol 2006;
115: 148–155.
32. Seguin JC, Walker RD, Caron JP et al. Methicillin-resistant Staphylo-
coccus aureus outbreak in a veterinary teaching hospital: potential
human-to-animal transmission. J Clin Microbiol 1999; 37: 1459–1463.
33. O’Mahony R, Abbott Y, Leonard FC et al. Methicillin-resistant Staphy-
lococcus aureus (MRSA) isolated from animals and veterinary person-
nel in Ireland. Vet Microbiol 2005; 109: 285–296.
34. Moodley A, Stegger M, Bagcigil AF et al. spa typing of methicillin-
resistant Staphylococcus aureus isolated from domestic animals and
veterinary staff in the UK and Ireland. J Antimicrob Chemother 2006;
58: 1118–1123.
35. Loeffler A, Pfeiffer DU, Lindsay JA, Magalha˜es RJ, Lloyd DH. Preva-
lence of and risk factors for MRSA carriage in companion animals: a
survey of dogs, cats and horses. Epidemiol Infect 2010; 14: 1–10.
36. Weese JS, Rousseau J, Traub-Dargatz JL, Willey BM, McGeer AJ, Low
DE. Community-associated methicillin-resistant Staphylococcus aureus
in horses and humans who work with horses. J Am Vet Med Assoc
2005; 226: 580–583.
37. Weese JS, Rousseau J, Willey BM, Archambault M, McGeer A, Low
DE. Methicillin-resistant Staphylococcus aureus in horses at a veteri-
nary teaching hospital: frequency, characterization, and association
with clinical disease. J Vet Intern Med 2006; 20: 182–186.
38. Cuny C, Kuemmerle J, Stanek C, Willey B, Strommenger B, Witte
W. Emergence of MRSA infections in horses in a veterinary hospital:
strain characterisation and comparison with MRSA from humans.
Euro Surveill 2006; 11: 44–47.
39. Cuny C, Strommenger B, Witte W, Stanek C. Clusters of infections
in horses with MRSA ST1, ST254, and ST398 in a veterinary hospital.
Microb Drug Resist 2008; 14: 307–310.
40. van Duijkeren E, Moleman M, Sloet van Oldruitenborgh-Oosterbaan
MM et al. Methicillin-resistant Staphylococcus aureus in horses and
horse personnel: an investigation of several outbreaks. Vet Microbiol
2010; 141: 96–102.
41. Ko¨ck R, Mellmann A, Schaumburg F, Friedrich AW, Kipp F, Becker
K. The epidemiology of methicillin-resistant Staphylococcus aureus
(MRSA) in Germany. Dtsch Arztebl Int 2011; 108: 761–767.
42. Witte W, Strommenger B, Stanek C, Cuny C. Methicillin-resistant
Staphylococcus aureus ST398 in humans and animals, Central Europe.
Emerg Infect Dis 2007; 13: 255–258.
43. Sieber S, Gerber V, Jandova V, Rossano A, Evison JM, Perreten V.
Evolution of multidrug-resistant Staphylococcus aureus infections in
horses and colonized personnel in an equine clinic between 2005 and
2010. Microb Drug Res 2011; 17: 471–478.
44. Faires MC, Gehring E, Mergl J, Weese JS. Methicillin-resistant Staphy-
lococcus aureus in marine mammals. Emerg Infect Dis 2009; 15: 2071–
2072.
45. Loeffler A, Boag AK, Sung J et al. Prevalence of methicillin-resistant
Staphylococcus aureus among staff and pets in a small animal referral
hospital in the UK. J Antimicrob Chemother 2005; 56: 692–697.
46. Kwon NH, Park KT, Jung WK et al. Characteristics of methicillin
resistant Staphylococcus aureus isolated from chicken meat and hospi-
talized dogs in Korea and their epidemiological relatedness. Vet Micro-
biol 2006; 117: 304–312.
47. Abdel-Moein KA, Samir A. Isolation of enterotoxigenic Staphylococcus
aureus from pet dogs and cats: a public health implication. Vector
Borne Zoonotic Dis 2011; 11: 627–629.
48. Wan MT, Fu SY, Lo YP, Huang TM, Cheng MM, Chou CC. Hetero-
geneity and phylogenetic relationships of community-associated meth-
icillin-sensitive/resistant Staphylococcus aureus isolates in healthy dogs,
cats and their owners. J Appl Microbiol 2011; 112: 205–213.
49. Lin Y, Barker E, Kislow J et al. Evidence of multiple virulence sub-
types in nosocomial and community-associated MRSA genotypes in
companion animals from the Upper Midwestern and Northeastern
United States. Clin Med Res 2011; 9: 7–16.
50. Weese JS, van Duijkeren E. Methicillin-resistant Staphylococcus aureus
and Staphylococcus pseudintermedius in veterinary medicine. Vet Micro-
biol 2010; 140: 418–429.
51. van Duijkeren E, Ten Horn L, Wagenaar JA et al. Suspected horse-
to-human transmission of MRSA ST398. Emerg Infect Dis 2011; 17:
1137–1139.
52. Devriese LA, Van Damme LR, Fameree L. Methicillin (cloxacillin)-
resistant Staphylococcus aureus strains isolated from bovine mastitis
cases. Zentralbl Veterinarmed B 1972; 19: 598–605.
53. Devriese LA, Hommez J. Epidemiology of methicillin-resistant Staphy-
lococcus aureus in dairy herds. Res Vet Sci 1975; 19: 23–27.
54. Armand-Lefevre L, Ruimy R, Andremont A. Clonal comparison of
Staphylococcus aureus isolates healthy pig farmers, human controls,
and pigs. Emerg Infect Dis 2005; 11: 711–714.
55. Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M. Methicillin-resistant
Staphylococcus aureus in pig farming. Emerg Infect Dis 2005; 11: 1965–1966.
56. Khanna T, Friendship R, Dewey C, Weese JS. Methicillin resistant
Staphylococcus aureus colonization in pigs and pig farm workers. Vet
Microbiol 2008; 128: 298–303.
57. Smith TC, Male MJ, Harper AL et al. Methicillin-resistant Staphylococ-
cus aureus strain ST398 is present in midwestern US swine and swine
workers. PLoS ONE 2008; 4: e4258.
58. Neela V, Mohd Zafrul A, Mariana NS, van Belkum A, Liew YK, Rad
EG. Prevalence of ST9 methicillin-resistant Staphylococcus aureus
among pigs and pig handlers in Malaysia. J Clin Microbiol 2009; 47:
4138–4140.
59. Cui S, Li J, Hu C et al. Isolation and characterization of methicillin-
resistant Staphylococcus aureus from swine and workers in China. J An-
timicrob Chemother 2009; 64: 680–683.
632 Clinical Microbiology and Infection, Volume 18 Number 7, July 2012 CMI
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 626–634
60. Guardabassi L, O’Donoghue M, Moodley A, Ho J, Boost M. Novel
lineage of methicillin-resistant Staphylococcus aureus, Hong Kong.
Emerg Infect Dis 2009; 15: 1998–2000.
61. Wagenaar J, Yue H, Pritchard J et al. Unexpected sequence types in
livestock associated methicillin-resistant Staphylococcus aureus (MRSA):
MRSA ST9 and a single locus variant of ST9 in pig farming in China.
Vet Microbiol 2009; 139: 405–409.
62. Lim SK, Nam HM, Jang GC, Lee HS, Jung SC. The first detection of
methicillin-resistant Staphylococcus aureus ST398 in pigs in Korea. Vet
Microbiol 2012; 155: 88–92.
63. Smith TC, Pearson N. The emergence of Staphylococcus aureus
ST398. Vector Borne Zoonotic Dis 2010; 11: 327–339.
64. Bens CC, Voss A, Klaassen CH. Presence of a novel DNA methyla-
tion enzyme in methicillin-resistant Staphylococcus aureus isolates. J
Clin Microbiol 2006; 44: 1875–1876.
65. Argudı´n MA, Tenhagen BA, Fetsch A et al. Virulence and resistance
determinants of German Staphylococcus aureus ST398 isolates from
nonhuman. Appl Environ Microbiol 2011; 77: 3052–3060.
66. Hallin M, De Mendonc¸a R, Denis O et al. Diversity of accessory gen-
ome of human and livestock-associated ST398 methicillin resistant
Staphylococcus aureus strains. Infect Genet Evol 2011; 11: 290–299.
67. Bos ME, Graveland H, Portengen L, Wagenaar JA, Heederik DJ. Live-
stock-associated MRSA prevalence in veal calf production is associated
with farm hygiene, use of antimicrobials, and age of the calves. Prev Vet
Med 2012; in press. doi: http://dx.doi.org/10.1016/j.prevetmed.2012.
01.002.
68. Graveland H, Wagenaar JA, Heesterbeek H, Mevius D, van Duijkeren
E, Heederik D. Methicillin resistant Staphylococcus aureus ST398 in
veal calf farming: human MRSA carriage related with animal antimi-
crobial usage and farm hygiene. PLoS ONE 2010; 5: e10990.
69. Lewis HC, Molbak K, Reese C et al. Pigs as source of methicillin-
resistant Staphylococcus aureus CC398 infections in humans, Denmark.
Emerg Infect Dis 2008; 14: 1383–1389.
70. van den Broek IV, van Cleef BA, Haenen A et al. Methicillin-resistant
Staphylococcus aureus in people living and working in pig farms. Epi-
demiol Infect 2008; 137: 700–708.
71. Denis O, Suetens C, Hallin M et al. Methicillin-resistant Staphylococcus
aureus ST398 in swine farm personnel, Belgium. Emerg Infect Dis
2009; 15: 1098–1101.
72. Tenhagen BA, Fetsch A, Stu¨hrenberg B et al. Prevalence of MRSA
types in slaughter pigs in different German abattoirs. Vet Rec 2009;
165: 589–593.
73. Guardabassi L, Stegger M, Skov R. Retrospective detection of methi-
cillin resistant and susceptible Staphylococcus aureus ST398 in Danish
slaughter pigs. Vet Microbiol 2007; 122: 384–386.
74. Huijsdens XW, van Dijke BJ, Spalburg E et al. Community-acquired
MRSA and pig-farming. Ann Clin Microbiol Antimicrob 2006; 5: 26
doi: 10.1186/1476-0711-5-26.
75. Witte W, Strommenger B, Stanek C, Cuny C. Methicillin-resistant
Staphylococcus aureus ST398 in humans and animals, Central Europe.
Emerg Infect Dis 2007; 13: 255–258.
76. Aubry-Damon H, Grenet K, Sall-Ndiaye P et al. Antimicrobial resis-
tance in commensal flora of pig farmers. Emerg Infect Dis 2004; 10:
873–879.
77. Gordoncillo MJ, Abdujamilova N, Perri M, Donabedian S, Zervos M,
Bartlett P. Detection of methicillin-resistant Staphylococcus aureus
(MRSA) in backyard pigs and their owners, Michigan, USA. Zoonoses
Public Health 2011; 59: 212–216. doi: 10.1111/j.1863-2378.2011.
01437.x.
78. Agersø Y, Hasman H, Cavaco LM, Pedersen K, Aarestrup FM. Study
of methicillin resistant Staphylococcus aureus (MRSA) in Danish pigs at
slaughter and in imported retail meat reveals a novel MRSA type in
slaughter pigs. Vet Microbiol 2011; 157: 246–250. doi: dx.doi.org/
10.1016/j.vetmic.2011.12.023.
79. Overesch G, Bu¨ttner S, Rossano A, Perreten VBMC. The increase of
methicillin-resistant Staphylococcus aureus (MRSA) and the presence of
an unusual sequence type ST49 in slaughter pigs in Switzerland. Vet
Res 2011; 7: 30. doi: 10.1186/1746-6148-7-30.
80. Go´mez-Sanz E, Torres C, Lozano C et al. Detection, molecular char-
acterization, and clonal diversity of methicillin-resistant Staphylococcus
aureus CC398 and CC97 in Spanish slaughter pigs of different age
groups. Foodborne Pathog Dis 2010; 7: 1269–1277.
81. Lee JH. Methicillin (oxacillin)-resistant Staphylococcus aureus strains
isolated from major food animals and their potential transmission to
humans. Appl Environ Microbiol 2003; 69: 6489–6494.
82. Kaszanyitzky EJ, Egyed Z, Janosi S et al. Staphylococci isolated from
animals and food with phenotypically reduced susceptibility to beta-
lactamase resistant beta-lactam antibiotics. Acta Vet Hung 2004; 52:
7–17.
83. Kwon NH, Park KT, Moon JS et al. Staphylococcal cassette chromo-
some mec (SCCmec) characterisation and molecular analysis for
methicillin-resistant Staphylococcus aureus and novel SCCmec sub-
type IVg isolated from bovine milk in Korea. J Antimicrob Chemother
2005; 56: 624–632.
84. Juha´sz-Kaszanyitzky E, Szila´rd J, Somogyi P et al. MRSA transmission
between humans and cows. Emerg Infect Dis 2007; 13: 630–632.
85. Umoh VJ, Adesiyun AA, Gomwalk NE. Antibiogram of staphylococcal
strains isolated from milk and milk-products. Zentralbl Veterinarmed B
1990; 37: 701–706.
86. Costa EO, Benites NR, Guerra JL, Melville PA. Antimicrobial suscep-
tibility of Staphylococcus spp. isolated from mammary parenchymas of
slaughtered dairy cows. J Vet Med B Infect Dis Vet Public Health 2000;
47: 99–103.
87. Erskine RJ, Walker RD, Bolin CA, Bartlett PC, White DG. Trends in
antibacterial susceptibility of mastitis pathogens during a seven-year
period. J Dairy Sci 2002; 85: 1111–1118.
88. Farzana K, Shah SNH, Jabeen F. Antibiotic resistance pattern against
various isolates of Staphylococcus aureus from raw milk samples. J Res
(Sci) 2004; 15: 145–151.
89. Turutoglu H, Ercelik S, Ozturk D. Antibiotic resistance of Staphylococ-
cus aureus and coagulase-negative staphylococci isolated from bovine
mastitis. Bull Vet Inst Pulawy 2006; 50: 41–45.
90. Feßler A, Scott C, Kadlec K, Ehricht R, Monecke S, Schwarz S.
Characterization of methicillin-resistant Staphylococcus aureus ST398
from cases of bovine mastitis. J Antimicrob Chemother 2010; 65:
619–625.
91. Holmes MA, Zadoks RN. Methicillin resistant S. aureus in human and
bovine mastitis. J Mammary Gland Biol Neoplasia 2011; 16: 373–382.
92. Garcia-Alvarez L, Holden MTG, Lindsay H et al. Methicillin-resistant
Staphylococcus aureus with a novel mecA homologue in human and
bovine populations in the UK and Denmark: a descriptive study. Lan-
cet Infect Dis 2011; 11: 595–603.
93. Gharsa H, Ben Slama K, Lozano C et al. Prevalence, antibiotic resis-
tance, virulence traits and genetic lineages of Staphylococcus aureus in
healthy sheep in Tunisia. Vet Microbiol 2011; 156: 367–373. doi:
dx.doi.org/10.1016/j.vetmic.2011.11.009.
94. Goni P, Vergara Y, Ruiz J, Albizu I, Vila J, Gomez-Lus R. Antibiotic resis-
tance and epidemiological typing of Staphylococcus aureus strains from
ovine and rabbit mastitis. Int J Antimicrob Agents 2004; 23: 268–272.
95. Quddoumi SS, Bdour SM, Mahasneh AM. Isolation and characteriza-
tion of methicillin-resistant Staphylococcus aureus from livestock and
poultry meat. Ann Microbiol 2006; 56: 155–161.
96. Ekkelenkamp MB, Sekkat M, Carpaij N, Troelstra A, Bonten MJ.
Endocarditis due to meticillin-resistant Staphylococcus aureus originat-
ing from pigs. Ned Tijdschr Geneeskd 2006; 150: 2442–2447.
97. Wieler LH, Ewers C, Guenther S, Walther B, Lu¨bke-Becker A. Meth-
icillin-resistant staphylococci (MRS) and extended-spectrum beta-
lactamases (ESBL)-producing Enterobacteriaceae in companion
CMI Petinaki and Spiliopoulou MRSA among animals and humans 633
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 626–634
animals: nosocomial infections as one reason for the rising prevalence
of these potential zoonotic pathogens in clinical samples. Int J Med
Microbiol 2011; 301: 635–641.
98. Lowder BV, Guinane CM, Ben Zakour NL et al. Recent human-to-
poultry host jump, adaptation, and pandemic spread of Staphylococcus
aureus. Proc Natl Acad Sci USA 2009; 106: 19545–19550.
99. Kluytmans J, van Leeuwen W, Goessens W et al. Food-initiated out-
break of methicillin-resistant Staphylococcus aureus analyzed by pheno-
and genotyping. J Clin Microbiol 1995; 33: 1121–1128.
100. Garcia-Graells C, Antoine J, Larsen J, Catry B, Skov R, Denis O. Live-
stock veterinarians at high risk of acquiring methicillin-resistant Staph-
ylococcus aureus ST398. Epidemiol Infect 2012; 140: 383–389.
101. Wulf MW, Sørum M, van Nes A et al. Prevalence of methicillin-resis-
tant Staphylococcus aureus among veterinarians: an international study.
Clin Microbiol Infect 2008; 14: 29–34.
102. Huber H, Koller S, Giezendanner N, Stephan R, Zweifel C. Preva-
lence and characteristics of methicillin-resistant Staphylococcus aureus
in humans in contact with farm animals, in livestock, and in food of
animal origin, Switzerland, 2009. Euro Surveill 2010; 15: pii19542.
103. Price LB, Stegger M, Hasman H et al. Staphylococcus aureus CC398:
host adaptation and emergence of methicillin resistance in livestock.
MBio 2012; 3: pii: e00305–pii: e00311.
104. Wulf MWH, Markestein A, van der Linden FT, Voss A, Klaassen C, Ver-
duin CM. First outbreak of methicillin-resistant Staphylococcus aureus
ST398 in a Dutch hospital, June 2007. Euro Surveill 2008; 13: pii: 8051.
105. van Cleef BA, Monnet DL, Voss A et al. Livestock-associated methi-
cillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect
Dis 2011; 17: 502–505.
106. Ko¨ck R, Siam K, Al-Malat S et al. Characteristics of hospital patients
colonized with livestock associated methicillin-resistant Staphylococcus
aureus (MRSA) CC398 versus other MRSA clones. J Hosp Infect 2011;
79: 292–296.
107. Grundmann H, Aanensen DM, van den Wijngaard CC et al. Geographic
distribution of Staphylococcus aureus causing invasive infections in
Europe: a molecular-epidemiological analysis. PLoS Med 2010; 7:
e1000215.
108. Hanson BM, Dressler AE, Harper AL et al. Prevalence of Staphylococ-
cus aureus and methicillin-resistant Staphylococcus aureus (MRSA) on
retail meat in Iowa. J Infect Public Health 2011; 4: 169–174.
109. Pu S, Han F, Ge B. Isolation and characterization of methicillin-resis-
tant Staphylococcus aureus strains from Louisiana retail meats. Appl
Environ Microbiol 2009; 75: 265–267.
110. Lim SK, Nam HM, Park HJ et al. Prevalence and characterization of
methicillin-resistant Staphylococcus aureus in raw meat in Korea. J
Microbiol Biotechnol 2010; 20: 775–778.
111. O’Brien AM, Hanson BM, Frina SA et al. MRSA in conventional and
alternative retail pork products. PLoS ONE 2012; 7: e30092.
112. Bhargava K, Wang X, Donabedian S, Zervos M, de Rocha L, Zhang
Y. Methicillin-resistant Staphylococcus aureus in retail meat, Detroit,
Michigan, USA. Emerg Infect Dis 2011; 17: 1135–1137.
113. Ogata K, Narimatsu H, Suzuki M, Higuchi W, Yamamoto T, Taniguchi
H. Commercially distributed meat as a potential vehicle for commu-
nity-acquired methicillin-resistant Staphylococcus aureus. Appl Environ
Microbiol 2012; 78: 2797–2802.
634 Clinical Microbiology and Infection, Volume 18 Number 7, July 2012 CMI
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 626–634
